Particularly, recent studies suggest that the outcome of suppressing autophagy in tumor development depends on the status of p53; in the absence of intact p53, loss of autophagy or the use of autophagy inhibitor accelerates tumorigenesis [36]. Here, TP53 is linked to neoplasm.